ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,239Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 175

$222K Total Retail Price of All Prescriptions

Rank: 22 out of 175

294 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 294 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

7% of this provider’s 294 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 6,643 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$31 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 407 380 1 1
OMEPRAZOLE 329 317 2 3
LEVOTHYROXINE SODIUM 289 274 3 2
LISINOPRIL 282 270 4 4
FUROSEMIDE 226 222 5 5
CITALOPRAM HBR 225 205 6 16
AMLODIPINE BESYLATE 213 198 7 6
POTASSIUM CHLORIDE 193 180 8 13
HYDROCHLOROTHIAZIDE 188 176 9 9
METFORMIN HCL 152 137 10 8
WARFARIN SODIUM 135 131 11 12
TRAMADOL HCL 126 124 12 18
ATENOLOL 111 105 13 14
LOSARTAN POTASSIUM 110 110 14 20
ZOLPIDEM TARTRATE 102 89 15 47
GLIMEPIRIDE 96 90 16 26
ALENDRONATE SODIUM 95 95 17 17
METOPROLOL SUCCINATE 93 83 18 15
DILTIAZEM 24HR CD 89 89 19 122
ATORVASTATIN CALCIUM 89 87 19 11
DONEPEZIL HCL 81 81 21 61
OXYBUTYNIN CHLORIDE 80 80 22 85
METOPROLOL TARTRATE 79 79 23 10
GABAPENTIN 77 60 24 22
AZITHROMYCIN 76 72 25 40
ALLOPURINOL 76 64 25 28
RANITIDINE HCL 74 55 27 25
ENALAPRIL MALEATE 67 67 28 50
TRAZODONE HCL 64 56 29 41
PRAVASTATIN SODIUM 64 62 29 19
HYDROCODONE-ACETAMINOPHEN 59 51 S3 31 7
SPIRONOLACTONE 57 57 32 70
SERTRALINE HCL 56 40 33 21
NAMENDA 56 56 33 89
TRIAMTERENE-HCTZ 54 53 35 51
AMITRIPTYLINE HCL 53 53 R 36 64
BUMETANIDE 53 53 36 93
CIPROFLOXACIN HCL 52 51 38 96
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 39 38 31
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 38 114
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.